Pharmacokinetics and Pharmacodynamics of Low Dose Mycophenolate Mofetil in HIV-Infected Patients Treated with Abacavir, Efavirenz and Nelfinavir

被引：0
|
作者：
Olga Millán
Mercé Brunet
Jaume Martorell
Felipe García
Elena Vidal
Isabel Rojo
Montserrat Plana
Teresa Gallart
Tomas Pumarola
Jose M. Miró
Jose M. Gatell
机构：
[1] Universitat de Barcelona,Servei Immunologia, Hospital Clínic, IDIBAPS
[2] Universitat de Barcelona,Servei Toxicologia, Hospital Clínic, IDIBAPS
[3] Universitat de Barcelona,Servei Infeccions, Hospital Clínic, IDIBAPS
[4] Universitate de Barcelona,Servei Microbiologia, Hospital Clínic, IDIBAPS
[5] Hospital Clinic de Barcelona,Servei Immunologia
来源：
Clinical Pharmacokinetics | 2005年 / 44卷
关键词：
Viral Load; Efavirenz; Mycophenolate Mofetil; Abacavir; Mycophenolic Acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：525 / 538
页数：13
相关论文
共 50 条
  • [41] Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children
    Wintergerst, U.
    Hoffmann, F.
    Jansson, A.
    Notheis, G.
    Huss, K.
    Kurowski, M.
    Burger, D.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (06) : 1336 - 1339
  • [42] The long-term pharmacokinetics and safety of adding low-dose ritonavir to a nelfinavir 1250mg twice-daily regimen in HIV-infected patients
    Justesen, US
    Hansen, IM
    Andersen, ÅB
    Klitgaard, NA
    Black, FT
    Gerstoft, J
    Mathiesen, LR
    Pedersen, C
    HIV MEDICINE, 2005, 6 (05) : 334 - 340
  • [43] Efavirenz dose reduction in HIV-infected patients: a long-term follow-up
    Lanzafame, Massimiliano
    Lattuada, Emanuela
    Cucchetto, Giulia
    Concia, Ercole
    Vento, Sandro
    AIDS, 2014, 28 (18) : 2789 - 2790
  • [44] Comparison of the In Vivo Pharmacokinetics and In Vitro Dissolution of Branded Versus Generic Efavirenz Formulation in HIV-Infected Patients
    Gervasoni, Cristina
    Baldelli, Sara
    Cerea, Matteo
    Cenderello, Giovanni
    Bini, Teresa
    Vimercati, Stefania
    Iardino, Rosaria
    Gazzaniga, Andrea
    Monforte, Antonella D'Arminio
    Clementi, Emilio
    Cattaneo, Dario
    THERAPEUTIC DRUG MONITORING, 2016, 38 (03) : 420 - 422
  • [45] Multiple-dose pharmacokinetics of delavirdine mesylate and didanosine in HIV-infected patients
    Morse, GD
    Cohn, SE
    Shelton, MJ
    Greisberger, C
    Cox, SR
    Della-Coletta, AA
    Freimuth, WW
    Reichman, RC
    CLINICAL DRUG INVESTIGATION, 2003, 23 (05) : 323 - 328
  • [46] Multiple-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in HIV-Infected Patients
    Gene D. Morse
    Susan E. Cohn
    Mark J. Shelton
    Carol Greisberger
    Steven R. Cox
    Andrew A. Della-Coletta
    William W. Freimuth
    Richard C. Reichman
    Clinical Drug Investigation, 2003, 23 : 323 - 328
  • [47] Comparison of pharmacokinetics and pharmacodynamics of mycophenolate mofetil in maintenance renal allograft recipients treated with tacrolimus or cyclosporine.
    Glander, Petra
    Hambach, Pia
    Bauer, Steffen
    Mai, Ingrid
    Neumayer, Hans H.
    Budde, Klemens
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 338 - 338
  • [48] Pharmacokinetics of indinavir/ritonavir (800/100 mg twice a day) combined with efavirenz in HIV-infected patients
    Aarnoutse, RE
    Brinkman, K
    Benetucci, J
    Begovac, J
    Stek, M
    Burger, DM
    AIDS, 2004, 18 (03) : 565 - 567
  • [49] Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults
    DeJesus, E
    Herrera, G
    Teofilo, E
    Gerstoft, J
    Buendia, CB
    Brand, JD
    Brothers, CH
    Hernandez, J
    Castillo, SA
    Bonny, T
    Lanier, ER
    Scott, TR
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) : 1038 - 1046
  • [50] Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks
    Wasmuth, JC
    Herhaus, C
    Römer, K
    Salzberger, B
    Kaiser, R
    Schliefer, K
    Voigt, E
    Rockstroh, JK
    AIDS, 2002, 16 (07) : 1077 - 1078
12345